SCHEMBL5239243

SCHEMBL5239243

C=C(O)C(N)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20529109 0.76
SCHEMBL142963 0.74
SCHEMBL7070827 0.70
SCHEMBL12720216 0.70
SCHEMBL13242309 0.70
SCHEMBL12461568 0.70
SCHEMBL12670153 0.70
Hydrochloric Acid SCHEMBL29199515 0.68
SCHEMBL13018309 0.68
Ammonia Solution, Strong SCHEMBL8894174 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1794122-A1 3-SUBSTITUTED-5- AND 6-AMINOALKYL INDOLE-2-CARBOXYLIC ACID AMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I Aventis Pharmaceuticals, Inc. (US) 2007-06-13 EP disclosed
WO-2006023467-A1 3-SUBSTITUTED-5- AND 6-AMINOALKYL INDOLE-2-CARBOXYLIC ACID AMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I&amp;epsiv; AVENTIS PHARMACEUTICALS INC. (US) 2006-03-02 WO disclosed
EP-0876161-B1 CONTRAST MEDIA NYCOMED SALUTAR INC (US) 2001-11-21 EP disclosed
EP-0876161-A2 CONTRAST MEDIA NYCOMED SALUTAR, INC. (US) 1998-11-11 EP disclosed
WO-1997026921-A2 CONTRAST MEDIA NYCOMED SALUTAR INC. (US) 1997-07-31 WO disclosed